TrialNCT07661641
A Study of [177Lu]Lu-A9-0631 and [225Ac]Ac-A9-0642 With [68Ga]Ga-A9-6217 or [177Lu]Lu-A9-0631 Imaging in GRPR+ Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
- Last update posted
- 09/04/2026
- Start
- 07/01/2026
- Sponsor
- Alpha-9 Oncology USA Inc.
- Specialties
- oncology
Conditions: Breast Cancer; Prostate Cancer; Colorectal Cancer; GRPR-positive Solid Tumors
Brief summary
This is a Phase 1-1b multicenter clinical study to evaluate the safety, efficacy, and dosimetry of \[177Lu\]Lu-A9-0631 and \[225Ac\]Ac-0642 in participants with Gastrin-Releasing Peptide Receptor (GRPR) expressing locally advanced, unresectable or metastatic solid tumors.
Protocol documents and results are not hosted here. Verify every detail on ClinicalTrials.gov.